Edgewater Capital Partners Invests in CBCC Global Research

May 27, 2025

Edgewater Capital Partners, a Cleveland-based private equity firm, has partnered with the shareholders and management of CBCC Global Research, a Bakersfield-headquartered clinical contract research organization (CRO). Edgewater's investment will support CBCC's growth by funding people, technology, and infrastructure to expand its clinical trial services across oncology, CNS, ophthalmology and other therapeutic areas.

Targets
CBCC Global Research
Sellers
CBCC Global Research shareholders and management team
Location
California, United States
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.